This company listing is no longer active
9JC Stock Overview
Through its subsidiaries, operates in the antimicrobial fabrics, textiles and flooring, and life sciences businesses in Europe, North and South America, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
HeiQ Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.052 |
| 52 Week High | UK£0.17 |
| 52 Week Low | UK£0.017 |
| Beta | 0.69 |
| 11 Month Change | -15.32% |
| 3 Month Change | -55.13% |
| 1 Year Change | -66.98% |
| 33 Year Change | -95.26% |
| 5 Year Change | n/a |
| Change since IPO | -95.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9JC | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 10.5% | -0.1% | 1.3% |
| 1Y | -67.0% | -0.3% | 7.9% |
Return vs Industry: 9JC underperformed the German Chemicals industry which returned -1.1% over the past year.
Return vs Market: 9JC underperformed the German Market which returned 7.9% over the past year.
Price Volatility
| 9JC volatility | |
|---|---|
| 9JC Average Weekly Movement | 25.1% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9JC's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 9JC's weekly volatility has increased from 18% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 200 | Carlo Centonze | www.heiq.com |
HeiQ Plc, through its subsidiaries, operates in the antimicrobial fabrics, textiles and flooring, and life sciences businesses in Europe, North and South America, Asia, and internationally. It offers functional textile technologies to provide hygiene, comfort protection, and resource efficiency; surface coatings and polymers; patented probiotic technology for cosmetics, water treatment, and cleaning products; and functional consumer goods for personal care, healthcare, and lifestyle. The company also offers research, technical implementation concept creation, feasibility analyses, test development, and products and process solutions.
HeiQ Plc Fundamentals Summary
| 9JC fundamental statistics | |
|---|---|
| Market cap | €9.07m |
| Earnings (TTM) | -€13.11m |
| Revenue (TTM) | €39.21m |
0.2x
P/S Ratio-0.7x
P/E RatioIs 9JC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9JC income statement (TTM) | |
|---|---|
| Revenue | US$41.55m |
| Cost of Revenue | US$26.32m |
| Gross Profit | US$15.22m |
| Other Expenses | US$29.11m |
| Earnings | -US$13.89m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.082 |
| Gross Margin | 36.64% |
| Net Profit Margin | -33.44% |
| Debt/Equity Ratio | 44.1% |
How did 9JC perform over the long term?
See historical performance and comparison